Minimal Residual Disease Testing Market Benefits from AI-Based...

added blog Other

2025-08-12 08:26:12 -

Minimal Residual Disease Testing Market Benefits from AI-Based Diagnostics

The global minimal residual disease testing market size was valued at USD 2.50 billion in 2024 and is projected to reach USD 4.50 billion by 2030, growing at a CAGR of 10.1% from 2025 to 2030. Growth in the MRD market is driven by the rising incidence and prevalence of cancer, rapid advancements in diagnostic technologies, and the increasing integration of MRD testing with...

0 Comments 0 Shares 15 Views 0 Reviews